Evaluation of the role of timolol 0.1% gel in myopic regression after laser in situ keratomileusis()

PURPOSE: To evaluate the efficacy of the concomitant administration of antiglaucoma medications namely timolol 0.1% gel in cases with myopic regression after myopic laser in situ keratomileusis (LASIK). DESIGN: Prospective observational clinical trial. SUBJECTS AND METHODS: Ninty five eyes of 75 pat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: El-Awady, Hatem E., Ghanem, Asaad A., Gad, Mohamed A.
Format: Artigo
Langue:Inglês
Publié: Elsevier 2010
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3729641/
https://ncbi.nlm.nih.gov/pubmed/23960881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjopt.2010.03.001
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires